We finally can reveal what we were working on last month, besides the first TNHC retreat. Together with the Canadian company Dimensions, we will Co-Create psychedelic retreats in Europe, starting this autumn in the Netherlands with magic truffle experiences. Dimensions offers safe and legal plant medicine-assisted experiences for personal growth and well-being.In December last year I was a guest at the Dimensions retreat and this changed my perspective on the topic of psychedelics, cannabis, retreats and the importance of somatic work. I Do think that cannabis can offer psychedelic insights too, helping you to heal on a really deep level. Let me quickly introduce Dimensions. This is a place to reconnect, an opportunity to heal and a path to lasting transformation. Whatever your intention. Dimensions invites you to unlock your potential for well-being while experiencing warm hospitality in luxurious natural settings. So of course I wanted to chat with the CEO of Dimensions, Christopher Dawson and the COO Andrew Galloway about their personal plant medicine journey, the idea of Cannabis retreats and cannabis as a ceremony, the importance of science informed and trauma informed retreats and of course we will outline how the New Health Club and Dimensions and the Co-Creation for a strong network of retreats in Europe can look like. https://dimensionsretreats.com/

My guest today is Cindy Gallop or Lucinda Lee Gallop. And she is quite something! I wanted to have Cindy on the show, because she engaged on a psychedelic journey (with 62) not because of mental health reasons. She embarked on a truffle journey, just out of very simple curiosity. And lust for life. And resetting perspectives. To me Cindy’s case also has an element for future ideas around longevity: what happens, if we keep our brain young? And how will this affect our body? Cindy says about herself to be “boringly drug resistant” but after her experience , things, aka her life changed. Cindy says. “ What it did just reinforce for me was a sense of history and the broadness of humanity. And the importance in the future, looking into the void, of finding light and connections.” Cindy Gallop I would say, is a real de-stigmatisation pro, a genius if it comes to tell it like things are. And then make them market ready. You guessed it, Cindy was an incredible advertiser, a female Don Draper, and we had many conversations over dinner about the rebranding or re-naming of psychedelics. Cindy studied English literature at Oxford University, receiving an MA in English language and literature. She was an English advertising consultant, founder and former chair of the US branch of advertising firm Bartle Bogle Hegarty, worked on accounts like Coca Cola, Ray Ban and Polaroid, In 2003, Gallop won the Advertising Woman of the Year award from Advertising Women of New York She is also the the founder of the companies IfWeRanTheWorld and MakeLoveNotPorn. According to the TED blog, Gallop's TEDTalk "Make Love Not Porn" was one of the "most talked about presentations'' at the 2009 TED conference. She founded her own brand and business innovation consultancy, Cindy Gallop LLC, in 2006. https://makelovenotporn.tv/ https://cindygallop.com/

This is our second life recording at Soho House Berlin. This time, we are talking about a topic that is just developing as we speak. Psychedelic leadership.What does it actually mean? Does it mean C Level people will engage in psychedelic experiences to look for better leadership practices and transformation? Does it mean at one point companies can offer psychedelic therapy to their employees? Does it mean we will look into psychedelics for inspiration if it comes to business or creative ideas? Or does it mean we are looking for a new leadership style all together, with the support of psychedelic experiences?Also, could we resolve epigenetic questions? Long standing political conflicts ? Many things to address and I was lucky to have a pretty good panel to reflect on all these questions In this episode I am joined by Jörg Reinboldt, MD at APX Axel Springer Porsche, entrepreneur, investorDr. Gesa Miczaika, General Partner at Auxxo Female Catalyst Fund, PhD Dmitrij Achelrod, Helping leaders thrive at Evolute Institute. |And Achim Feige,.Co -Founder of Vertical Development, Transformation Architect I Human Potential Coach.

Dr. Molly Maloof, physician and entrepreneur, kind of the female pendant to Andrew Huberman, is finally on the show today! Molly Maloof is one of the first people I read about, in terms of the new psychedelic space. Molly is one of the people in the psychedelic space, who marries science, medicine and psychedelics. Working on future topics in psychedelics, he has a pretty impressive track record of engagements in the new health space. She is the Founder & CEO, Adamo Bioscience, working on biological, psychological, psychedelic, and technological solutions to become the foremost scientific company perpetuating the power of love. She was a lecturer at Stanford University, taught the course “Live Better Longer: Enhancing Healthspan for Longer Lifespan” within the Wellness Department of the School of Medicine. (She received the highest student ratings in the department) She is the founder of DrMolly.co, a modern health and wellness media brand that inspires, educates, and motivates people to make the right
lifestyle choices so they can actualize their potential. She is the medical advisor: for Neurohacker, Drugs over Dinner, Osmind ect. Now, Molly has just released her new book “The Spark Factor”. “A breakthrough program for women to revive their lost energy and vitality, developed by a leading biohacker and physician. In her book, Molly talks about the spark we are all looking for on a daily basis. With cutting-edge biohacking insights, strategies for personalized nutrition, hormonal health and stress management, The Spark Factor is the book women have been waiting for to help them reclaim their vitality and achieve lasting health.” Molly and I talk about supplement overkill and pill fatigue the redefinition of stress and health the possibility to address sexual trauma with the support of psychedelics sexual psychedelic therapy for the masses, the limitations of classic couples therapy and why we share so many phantasies around love drugs and love potions. More Info: https://drmolly.co/

This is the last episode for 2022 and what a year it was. But before 2023 starts, we have a great episode for you, which gives you a taste of what’s to come at TNHC in 2023: live podcasts and events with an audience. I find this such an energetic experience to have an audience in the room and also provide room again for live Q & A. My guest was Rock Feilding-Mellen. He is from the family of Beckley organisations in the UK. And one of these companies is Beckley Retreats, which he co-founded with his mother, Amanda Feilding, who is also the founder and CEO of the Beckley Foundation, a great friend and inspiration to me. The Beckely foundation spear-headed much of the most groundbreaking scientific research upon which the new psychedelic renaissance is being built right now. But being the son of the “Queen of the Psychedelic Renaissance” likes Forbes calls Amanda, wasn’t always easy for Rock. In this episode Rock talks about his route, via business and politics, to the realisation of how transformational and healing psychedelic assisted therapy can be. And how Europe will play a big part in the current booming psychedelic renaissance. https://www.beckleyfoundation.org/

My guest today is Patrick Cox and I have to say, he is a very special guest, because I bought his shoes to be cool. Patrick’s shoes made you belong to the so called cool Britannia in the 90ties: The band Oasis wore them, glamorous DJs and rockstars, cool Londoners, the cool nightlife world wore them. More than that. The whole fashion world liked Patrick’s fashion taste. Patrick was a design super star, his nickname, Janet Jackson gave it to him, was "Party Pat". And Party Pat had everything. Celebrity friends like Elton John lots of money, charm, party stamina, talent, humour, until these things turned out to cover up his old trauma, the one that he experienced at age 4. Patrick never thought about it any more. But a few years ago, Patrick lost everything, his company and his ability to ignore the old trauma with his certified tools: travelling, partying and ignoring. So he tried everything, to save his mental health, but nothing worked. He even told his friends about a possible suicide. Before it was too late, he found toad venom, aka 5 MeoDMT. Toad Venom is found in the poison of Bufo alvarius, a toad native to the Sonoran desert in Mexico. After a few experiences, Patrick said, he didn’t hate himself any more. he found out, there was nothing wrong with him. The only question was, who would he be now? Patrick and I talk about how an intervention form Elton Johns feels like, how alcohol lost it’s so called cool, why heavy partying and depression are siblings, how generation X never leaned anything about healing. And how trauma, you have experienced so long ago, will catch up with you, even if you have everything you think we should have.

Tobias Silberzahn is a Partner in McKinsey’s Berlin office where he is a member of the Healthcare Practice and the Innovation Practice. McKinsey, called “The Form”, is one of the most famous management consulting groups and supposed to know it all. They charge corporations top dollar to help them run with state-of-the-art efficiency. McKinsey gets called in when things are good or bad to help bosses make difficult decisions. Over the last 13 years with McKinsey, Tobias has served mainly digital health startups, established healthcare companies and ministries of health. He lead McKinsey's global Health Tech Network, a community of >1500 digital health companies. His focus area is healthcare innovation and health-tech business building where he supports clients on R&D, commercialisation and scaling questions, he also hosts the McKinsey MedTech R&D Roundtable, the Pharma Technical Development Forum. Within McKinsey, he co-leads the health & wellbeing programs for employees in Germany and Austria, focused on sleep, nutrition, stress management and fitness. So Tobias needs to look into new mental health tools if it comes to employees, but at one point he might look as McKinsey into psychedelic pharma companies. Tobias and I talk about the great resignation, the idea of health that Generation Z, Millennials and generation X has developed and the future of a corporate mental health can look like. And, as you can imagine, I try to engage with Tobias in a conversation about how psychedelics will enter a future work space, since all the current corporate companies are really challenged and need to change from within. Lets see, how.

I can finally welcome Dr. Gabor Maté on the show! One of the most empathic, unapologetic and science driven people in the mental health space. I love that combination! And yes, we are also talking about psychedelics and trauma, but what I really like about Gabor is that he sounds like a contemporary, cool philosopher, helping to explain the exciting and disruptive times we live in. Dr. Gabor Maté is a Hungarian-Canadian physician and author. He has a background in family practice and a special interest in childhood development and trauma and in their potential lifelong impacts on physical and mental health, including on autoimmune disease, cancer, attention deficit hyperactivity disorder (ADHD), addictions, and a wide range of other conditions. Maté's approach to addiction focuses on the trauma his patients have suffered and he looks to address this in their recovery. We address, how most psychiatrists today are trained in a narrow fashion, Gabor’s ayahuasca ceremony and how he learned about his closed heart, the deepest pain and the deepest love and that our healing in the present and within ourselves. I can highly recommend really all of his books.

Jamie Wheal is the author of Recapture the Rapture: Rethinking God, Sex and Death In a World That's Lost Its Mind, and the Pulitzer-nominated global bestseller Stealing Fire: How Silicon Valley, Navy SEALs, and Maverick Scientists Are Revolutionizing the Way We Live and Work. He is the founder of the Flow Genome Project, an international organization dedicated to the research and training of human performance. His work and ideas have been covered in The New York Times, Financial Times, Wired, Entrepreneur, Harvard Business Review, Forbes, Inc., and TED. He has spoken at Stanford University, MIT, the Harvard Club, Imperial College, Singularity University, the U.S. Naval War College and Special Operations Command, Sandhurst Royal Military Academy, the Bohemian Club, and the United Nations. Jamie and I talk about the collapse of meaning in the the last decades and how meaning 3.0 could actually look like. What a modern “Alchemist Cookbook” is and why ethical cult building could be interesting. Plus: Jamie explains how flow looks like and what is has to do with the six neurotransmitters. And of course we talk about the current state of psychedelics and how to avoid “bliss junkies and epiphany whores,” as he says. But still, will the future be your and my brain on psychedelics? https://www.flowgenomeproject.com/ https://www.stevenkotler.com/book-pages/stealing-fire Please note also: The New Health Club is now a proud supporter of International Therapeutic Psilocybin Rescheduling Initiative, a global coalition working to reschedule psilocybin under the 1971 Convention on Psychotropic Substances. With partner organizations such as MAPS, the Beckley Foundation and Drug Science. ITPRI is working bring down barriers to advancing psychedelic medicine. Please check them out at reschedulepsilocybin.org and consider donating to support their work.

Robert Bent works with the VC fund Vine Ventures and is co-founder and CEO at Othership, a global community to improve mental health in an accessible way. Othership combines beautiful social spaces that deliver peak experiences and a mobile app that teaches breathwork. Prior to Othership, Robbert was Ecosystem Growth lead at the Ethereum Foundation. He graduated from the Richard Ivey School of Business. Roberts story is a modern one. By late 2013, after being super successful, Robert hit rock bottom. He felt burnt out, low, tired from his career in finance, was struggling with a substance abuse problem. He escaped to Israel, tried a ten day Vipassana retreat, finally went to Peru to try Ayahuasca.From here, Robert's life changed: he engaged in breath work practices, joined Vine Ventures and co-founded “Othership". Roberts vision, as he says,” is to create space that encourages openness to the awe, belonging, and interconnectivity that animates the human experience for a more joy-filled life and living.” He is building a platform that includes physical spaces, a mobile app, a concert tour and a global community. Robert and I talk about the Othership Community.how to use ice bathing and sauna to keep reflecting on your psychedelic experience, why people stop consuming alcohol once they engaged in psychedelics and how a future life with an integrated idea of psychedelics looks like. https://www.othership.us/app https://www.othership.us/physical https://vine.vc/

Julie Holland is an American psychopharmacologist, psychiatrist, and author. She is an really important voice in the new psychedelic world, we are just creating. She is the author of five books, including Moody Bitches, Good Chemistry, Weekends at Bellevue: Nine Years on the Night Shift at the Psych ER, a memoir documenting her experience as the weekend head of the psychiatric emergency room at Bellevue Hospital in New York City. She is an advocate for the appropriate use of consciousness expanding substances as part of mental health treatment, she is a medical monitor for MAPS studies, which involve, in part, developing psychedelics into prescription medication.Holland sits on a few advisory board, for example Palo Santo and to me, she is one of the most inspiring people in the space. What I like about Julie? She is non judgemental, she always sees the bigger picture in the psychedelic renaissance, and she is a lot fun to talk to. Please enjoy! http://drholland.com/

And just like that, there will be a whole new generation of politicians working on integrating psychedelic assisted therapy in the healthcare system and into new laws. How will the BTM (Betäubungsmittelgesetz in Germany) look like? Will we see a decentralization of mental health care? Why is pretty much everyone microdosing, although it is still really illegal? I am thrilled to talk to Mario Brandenburg from the FDP party today about the coming years, psychedelics and yes, Germany. Mario Brandenburg, born in Rhineland-Pfalz, is a spokesman for research, technology and innovation for the Free Democrats FDP (https://www.fdp.de/) Brandenburg is in the German Bundestag, chairman of the Education and Research Working Group, deputy member of the Digital Agenda Committee and member of the german Bundestag, Last year, he was one of the first politicians in Germany, who started to look into the possible rescheduling of psilocybin and made a request, how the old government under Angela Merkel could be encouraged to spend more money on clinical trials in terms of psychedelics. Now, since the election, Brandenburg is part of the new government and might be one of the german politicians engaging in making psychedelic assisted therapy available in Germany in the coming years. In May 2021, Brandenburg and some FDP colleagues submitted a so-called "Kleine Anfrage zu Medizinische Forschung mit Psilocybin und anderen psychedelischen Wirkstoffen in Deutschland”, in which he presented a list of questions to the federal government at the time, on the basis of which the government had to provide information about the current assessment of psilocybin as a therapeutic agent. We talk about legalization of cannabis in Germany and the decriminalization movement in the US, the decentralized mental health models and what would happen if you don't have to wait months to see a psychiatrist or therapist, the War on Drugs, why FDP leader Christian Lindner is talking about ending the criminalization of users and 'draining the black market’, why the Germans are afraid of microdosing and Silicon Valley why after the pandemic and Covid, we might need a speedy decriminalisation of new psychedelic tools and therapy that will help us to really cope with the massive wave of mental health problems.

Journey Clinical, Jonathan Sabbagh and Myriam Barthes, is my guest today. VCs named their company one of the top 15 startups in the psychedelic field. Journey Clinical is a turnkey telehealth platform that enables licensed psychotherapists to include legal, evidence-based Psychedelic Assisted Psychotherapies (PAP) in their practice, starting with Ketamine-Assisted Psychotherapy (KAP). Their novel decentralized clinic model provides member psychotherapists with unprecedented access to a KAP-trained medical team, as well as a robust care management platform designed to deliver personalized treatment plans for enhanced clinical outcomes. Myriam describes the new clinical system as a triangle. In the first corner is the patient, in the second the journey clinical doctor, who is able to describe and administer the ketamine, in the third corner is the Journey Clinical member psychotherapist, vetted and often independent, who works with the patient after the treatment. Jonathan describes the company as a “one stop shop where all the required treatments get offered to you”. Which means, as a patient, you would not have to run around to physicians, psychiatrists or therapists,who would eventually contradict each other in their diagnosis or where at least one party would not be open to Ketamine Assisted psychotherapy. Journey Clinical is your new psychedelic in house doctor. Both founders have a background in finance and both have experienced how their lives have transformed with psychedelics. Jonathan, working in hedge funds, suffered from a heavy burn out and undiagnosed PTSD and addiction condition, he looked into an ayahuasca and MDMA experiences. Myriam is a firm believer in plant medicine, she had her own psychedelic healing story.We talk about, how therapists join the network, can access educational videos , then join peer consultation groups and then can start referring patients to the ketamine therapy, how Ketamine can support tapering off antidepressants that patients will still need to take, how repressed feelings and underlying topics of patients made their way to the top during COVID, which amplified peoples crisis and depression even more, how with a few Ketamine Assisted Psychotherapy sessions things start to bubble up, how the modern psychedelic clinic can look like very soon. https://www.businessinsider.com/list-top-psychedelics-startups-according-to-vcs-investors-2021 https://www.journeyclinical.com/

My guest on The New Health Club Show today is Sa'ad Shah, managing partner of the Noetic Fund. Saad basically grew up all over the world, went to the JFK School in Berlin, worked in real estate banking, corporate credit, and derivative sales & trading.–and he holds a BA in Economics and Political Science from Columbia University.The Noetic Fund is a powerful investment group in the new psychedelic field, a group of venture funds launched by Grey House Partners GP Inc. to invest in emerging and early-stage wellness, therapeutic and pharmaceutical companies around the globe, The fund has $170 million in assets under management and is one of the venture-capital firms that's deployed the most funding into the psychedelic industry. The firm has invested $56 million in psychedelics since early 2020, when Shah started the fund. (Companies like Beckley Psytech,Gilgamesch, Bexson, ASRI, CaaM/Tech, Eleusis)Sa'ad and I talk about his interest in theology and mysticism as an investor and eventually taking ayahuasca in Brazil: his own classic hero’s-journey type of story. We address how his own interest and fascination with psychedelics became his new path in life, and what he is looking for, when he invests in a company How to nurture the “the scientific advancement of mental, emotional, psychological and physical health by investing in alternative therapies, modalities, and sciences that are committed to optimising our human experience” which is the Noetic vision and no small plan. (https://noeticfund.com/)

Today I am talking about couples and (magic) truffles, and yes, I mean psychedelic assisted couples therapy. So why could this type of therapy be groundbreaking for the coming years? Why could it be a version of therapy 2.0? And if so, what would it look like? Who would you and your partner be, if you met without the trauma you might carry with you? Today, we got two experts, who are executing an interesting version of truffle assisted couples therapy. I talk to the therapist Jeanien Souren and psychiatrist Hans van Wechem, both are in charge of couples therapy at Field Trip in Amsterdam. With an extensive professional career in mental health, Jeanine Souren holds degrees in psychology, psychotherapy, clinical sexology and couples & family therapy. She is accredited and licensed in the Netherlands and has worked as a lead clinician in several mental health settings. She is passionate about the therapeutic potential of psychedelics in combination with psychotherapy. Jeanine believes that by tapping into the deep psyche through psychedelics, suppressed patterns, emotions and beliefs can be made conscious again, allowing for healthy change. Hans van Wechem has almost 30 years of experience in psychiatry and started his career as a registered couples and family therapist before specializing in (group) psychotherapy of patients with early childhood trauma and attachment disorders. After a life-changing psychedelic experience, he recognized the potential of psychedelics in therapy. He now contributes to projects such as MAPS in their efforts to investigate MDMA for the treatment of PTSD and has a wide network in the psychedelic community. His main interest lies in contributing to a future in which the use of psychedelics will become widely accepted, both as an evidence-based treatment and as a powerful catalyst for personal and spiritual growth. https://www.fieldtriphealth.nl/

My guest today is Onur Yildirim, Director of Field Trip Health Amsterdam, a place that offers legal, safe and vetted experiences and possibilities to rediscover life through psychedelics. Field Trip Health stands for scientifically supported, legal psychedelic experiences that liberate and inspire you, and works with a step-by-step, professional approach to the use of psychedelics. This includes preparatory sessions and integrative therapy sessions. In Amsterdam Field Trip is working with truffles, in The US and Canada with ketamine. Onur, who leads a team of experienced therapists and psychiatrist at FT; was originally trained in clinical psychology and worked as a psychologist during the first years of his career. Later, Onur earned his PhD in neuroscience from Radboud University and worked in the R&D and MA of established pharmaceutical companies such as Johnson & Johnson and Novartis, where he championed the research of psychedelic molecules as potential antidepressants. After his time in the pharmaceutical industry, he began his entrepreneurial career which eventually led him to Field Trip. Onur and I talk about what happens if you make the decision to engage in a psychedelic journey at FT, who are the people that are interested in this and why the times of Covid are encouraging people to look into psychedelic support systems, if possible. And full disclosure, I have done a guided Truffle experience at Field Trip in Amsterdam and it brought me many new insights. I decided to engage in a truffle experience twice year - a tool to support my own life's and founder's journey.

My guests today are the architects Ester Bruzkus and Peter Greenberg and you might wonder: what will we talk about in a podcast like this one, if not about psychoactive compounds and psychedelics? And where does architecture comes in?Founded in 2002 in Berlin, Ester Bruzkus Architekten is an internationally established architecture and interior design practice with global ties, but based in Berlin. They are well known for extensive experience with design at many scales: from the design of tables and furniture to exquisite residences and workspaces to international theatres, restaurants and hotels. Ester was named as one of Architectural Digest’s “Top 200 Influencers in the Design World,” Growing up in Berlin, she studied architecture at Berlin’s Technical University and later at the School of Architecture in Belleville, Paris. Before founding her own Berlin office in 2002. Peter received his Master of Architecture from Harvard’s Graduate School of Design and graduated cum laude with Distinction in Architecture from Yale University where he also studied philosophy and the history of art. He is a licensed architect in the United States in Massachusetts and New York and is a certified Interior Designer. Since Peter has become Partner, the firm has won several international design competitions, has won many design awards, and has completed several significant projects, including the restaurants Remi and Villa Kellermann Tim Raue, and projects for Relaxound, Volkswagen’s Autostadt, and the PSD Bank. As you can see, here are two pros to talk about trauma, but this time not in brains, but in buildings and houses. The question is though, can buildings be as traumatized from severe historic incidents, as much as brains? And could this have an effect on people living in these buildings? Of course, the follow up question I am asking myself would be: could the trauma and the aura of a building be transformed, if these buildings might host psychedelic treatments and can we help buildings to heal? And redefine them? ? But let’s ask Ester and Peter, the experts on room karma and real building therapists. (https://esterbruzkus.com/)

My guest is Patrick Moher, CEO at Microdose Psychedelic Insights and creator of the Wonderland Psychedelic Conference in Miami. Patrick is an entrepreneur working in Psychedelics and Cannabis. He is a passionate and unapologetic environmentalist, founded Ethical Image, co-founded a couple of companies. I have met Patrick many times last year, mostly on Air Table, where he hosted the Micro Dose conference virtually. With Microdose online, one was able to see, what was happening in the incredible new field and the big names of the psychedelic renaissance all made their appearance.But now, Wonderland is near, the first big IRL conference in Miami, where most people in the psychedelic world will meet the first time. (Who knows, maybe Wonderland might become the Art Basel Miami for Psychedelics? )The event will certainly be an important meeting of science, capital and entertainment, meaning names like Mike Tyson and Lamar Odom speaking about their personal healing with the support of psychedelic therapy. A new development in the recent entertainment world, that I think is becoming very interesting, helping to destigmatize the psychedelic topic. Patrick and Wonderland are providing the first IRL experience for the psychedelic world in years.

My guests today are Daniel Goldberg and Tim Schlidt, founders of the Palo Santo fund. The two them an their really impressive team got a big plan for the coming years: investing across the new psychedelic ecosystem and funding a new paradigm in well being.Palo Santo’s diversified investment fund is helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions needed in today’s world. Daniel Goldberg began seeing mental health as part of a spectrum and not something that needs to be so pathologized.As a founder of Palo Santo and Bridge Investments, Daniel has been actively investing with and supporting inspired entrepreneurs for 20 years. Years ago he saw the transformational potential of psychedelic medicines and has developed a deep network of relationships across the psychedelic research and business communities. His passion for the space is purpose‐driven and science informed. He is thrilled to be a part of Palo Santo’s mission of supporting promising treatments while ensuring widespread access to safe, legal, and effective solutions. Tim Schlidt brings extensive knowledge investing across life sciences and healthcare services, and has held a lifelong passion for understanding and improving treatments for CNS disorders. He believes psychedelics are poised to shift the paradigm in mental health treatment and his primary mission in co-founding Palo Santo is to invest in companies and solutions that allow for broad access to those most in need of mental health care. Prior to co-founding Palo Santo, Tim covered the life sciences and health care services sectors as a private equity investor at Madison Dearborn Partners and an investment banker at J.P. Morgan and Greenhill. We talk about Daniels and Tims personal psychedelic experience they had BEFORE the founding of Palo Santo, the shift and the incredible change they saw coming, when a new generation of scientists engaged in psychedelics, about the psychedelic pharma model and what compound is Daniels and Tims favorite and we chat about what will possibly be happening and what I will see, if I would dare to take 5 MEO DMT: but that will happen on the next episode. https://www.palosanto.vc

Dave Rabin is an MD, PhD, a neuroscientist, board-certified psychiatrist, health tech entrepreneur & inventor who has been studying the impact of chronic stress in humans for nearly 15 years, particularly non-invasive therapies for treatment-resistant illnesses like PTSD. He is the co-founder & chief innovation officer at Apollo Neuroscience and the co-founder & executive director of The Board of Medicine. In addition to his clinical psychiatry practice, Dr. Rabin is currently conducting research on the epigenetic regulation of trauma responses and recovery to elucidate the mechanism of psychedelic-assisted psychotherapy and the neurobiology of belief. He is a practitioner of ketamine assisted psychotherapy (KAP) and is trained in MDMA assisted psychotherapy. With Molly Maloof, Dr. Dave Rabin is co-hosting the psychedelic news hour on clubhouse.(https://www.psychedelicnewshour.com/) We Talk about listeners on Club House that call in high and how to give them a little integration therapy on air . We talk about why epigenetic trauma is such specific thing, hardly explored, but now a really big topic in the psychedelic context and we talk benefits of Ketamine therapy done at home and of course we talk about Dr Rabins company Apollo. Apollo Neuroscience was born from research at the University of Pittsburgh. David Rabin and Greg Siegle PhD worked together at the Program in Cognitive Affective Neuroscience to develop and scientifically prove out the Apollo technology and discovered that certain combinations of low frequency inaudible sound waves (vibration that you can feel, but can’t hear) can safely and reliably change how we feel through our sense of touch, and that we can measure those physiological changes in near real time. Think of Apollo as a smart bracelet that you can wear around your wrist or ankle and works to give you stress-reducing buzzes in times of need. It syncs to the brand’s app, so you can control its touch therapy functions from your phone.I used Apollo often during the pandemic last year and I fell asleep much easier with it, so I can highly recommend it. Apollo calms your nervous system down in very gentle, but effective way. And since you are a part of amazing the The New Health Club Community, you get a 10% discount on the order of the Apollo. Just head over to www.apolloneuro.com and put in the promo code “newhealth 10” Apollo Partner One Sheet Dr. David Rabin's website Apollo Apollo Research

What if Palestinians and Israelis would do an ayahuasca ceremony together? Would there ne more empathy and mutual understanding after the ceremonies? Scientist Leor Roseman and Peace Activist Antwan Saca really wanted to see what happened then. And so they arranged it, and created a study for The Imperial College in London. They recently launched the study “Relational Processes in Ayahuasca Groups of Palestinians and Israelis. Leor Roseman is a postdoc at the Centre for Psychedelic Research, Imperial College London, where he received his Ph.D. and MRes, under the supervision of Dr. Robin Carhart-Harris and Prof. David Nutt. His research is focused on the neural and psychological correlates of the psychedelic experience, and the therapeutic application of psilocybin for depression. Currently, Leor is investigating the psychosocial potential of psychedelics. Antwan Saca was born in Jerusalem to a Christian family from the city of Bethlehem. He has spent his adult life working towards the dream of peace and justice in the Holy Land. He spent five years at the Holy Land Trust serving also as director of programs, where he experienced community-healing approaches that strengthened his interest in non-violent compassionate activism. Since then, he’s focused on community dynamics and the many forms of personal/collective experienced and inherited trauma that influence conflict resolution in the Holy Land. He believes that healing the pain of the past is a prerequisite for healthy relations between nations and—ultimately—peace. Antwan serves as an associate at Leaders Quest. https://www.frontiersin.org/articles/10.3389/fphar.2021.607529/full https://www.imperial.ac.uk/people/leor.roseman13 http://www.leadersquest.org

Diana Kinnert is a German politician, political consultant, and publisher. In 2015 she became the youngest chief of staff in the history of the Bundestag when she ran the parliamentary office of Peter Hintze. She is a frequent media commentator on public policy in Germany, and is affiliated with a number of think tanks and advisory committees of the Christian Democratic Union of Germany. Kinnert has the right amount of forward thinking and meeting people where they are at. She is also a firm believer that mental health becomes one of the most important things in our society. And, that loneliness can be looked upon as an illness. (In some countries, this is an accepted fact.) I highly recommend Dianas book “Die neue Einsamkeit: Und wie wir sie als Gesellschaft überwinden können” or “The new lonley”. Diana and I talk about this “new lonely” and how it affects not only older people, but a whole new generation of people under 30. There is a certain way of living very casually, not committed to things and people, that leaves a lot of us sad and disconnected. Something that is sometimes hard to figure out or even realise. Especially since this generation is perfectly connected in the digital world. More than anyone else. This explains to me, why we get lots of requests at The New Health Club from young people in their 20 or 30 about micro dosing, and most people tell us they would like to feel, to reconnect, but often can’t say with what and how. The “new lonely”and the rise of psychedelics and psychedelic therapy, is strongly connected. And this is our big topic here.

When I read about the “Veteran Navy SEAL Advocates for Psychedelic Assisted Therapy” called Marcus Capone, I was wondering, what was this all about? A Navy Seal and psychedelics? I kept reading and quickly Amber Capone, Marcus’ wife, was introduced in the articles, Amber wanted to save her husband from PTSD and, yes, suicide. And make it possible for war veterans to get in touch with psychedelic-assisted therapy by founding the organization Vet Solutions. Amber’s and Marcus’ mission today is to end the veteran suicide epidemic by providing resources, research, and advocacy for U.S. military veterans seeking psychedelic-assisted therapies. Vet Solutions helps veterans and their spouses to access treatment with psychedelic therapies including iboga/ibogaine, ketamine, psilocybin, MDMA, 5-MeO-DMT, and ayahuasca. So far in the US. But their model can work on a global level. The story of Marcus and Amber is a pretty strong one. When Marcus was medically retired after 13 years and multiple combat deployments as a U.S. Navy SEAL, Marcus and Amber thought that life would return to normal. Instead, their struggle had just begun. Marcus was experiencing an escalating myriad of challenges, including depression, isolation, cognitive impairment, excessive alcohol use, headaches, insomnia, and impulsivity. Marcus was diagnosed with post-traumatic stress disorder (PTSD), but, instinctively, Amber felt there was more to be discovered. After learning about the effects of blast waves, concussive, and subconcussive brain injuries, everything started to become clear. Marcus’ military career as an explosives expert, combined with his prior years of contact sports, had left him with the invisible wounds of traumatic brain injury (TBI), a condition that has significant overlap with PTSD and is often not properly diagnosed. So here they are, on the podcast, talking about their journey. https://vetsolutions.org/

Meet the Plant Medicine Law Group , the first law firm to emerge in the space with the express purpose of serving the psychedelic and cannabis industries. Partners Adriana Kertzer, Serena Wu, and Hadas Alterman are entering their 8th month with a full roster corporate and nonprofit of clients in both industries. They are here today with the first attorney they added, Allison Hoots, who specializes in religious exemptions for psychedelic use, to reflect on their growth, what they’ve learned, and what they hope to accomplish moving forward. I am a really big fan of the Plant Medicine Law Group, since we started to be present in the psychedelic ecosystem at a similar time, and I love the way they look at psychedelics and the renaissance we are just experiencing. Also they contribute to one of the most important parts in the new psychedelic world: the legal framework.So how do you work in an industry that is working with mostly illegal substances? https://www.plantmedicinelaw.com/

Heard of the potential of psychedelics for new ideas on leadership and supporting your creativity as an entrepreneur or executive? Meet my guest and expert on this today! It is Jonathan de Potter, the founder of Behold Retreats a special legal, vetted and safe retreat for leaders, executives and entrepreneurs. And btw, a portion of Beholds revenues is going to Fireside Project - the free psychedelic harm reduction hotline. Jonathan talks to me about the psychedelic CEO, how integration of the psychedelic experience is on of the most important topics after the psychedelic experience itself, how new ideas for a company can come out of an experience all together. But also how much the, often stressed and high pressured personal life of a CEO is connected to all of this and that there is no end of evolution for your consciousness, even if you try so hard to achieve it. So if you you are an entrepreneur , CEO or in a leadership position and you know that the top down fear based hierarchy in companies is in the process of being replaced by a more servant leadership. And that we need new ideas, new structures and new insights for our world, not only in business. https://www.behold-retreats.com/ https://firesideproject.org/

Yes, it’s the famous Hamilton Morris who is my guest today. Hamilton is an American journalist, documentarian, and scientific researcher. He is the creator and director of the television series “Hamilton's Pharmacopeia”, in which he investigates the chemistry, history, and cultural impact of various psychoactive drugs. Now Hamilton is on the third season of his show, which was released on January 4, 2021.The show runs on Vice TV and YT. Hamilton started to engage early into very personalised and you could say customised research of drugs and substances. He always had an interesting aura around him on camera, a mixture of a daring guinea pig and scientist. The episodes of his show had names, that made it clear . how un judgmental and curious Hamilton was approaching psychedelic substance as his topic. At this point in his life as a psychedelic expert, Hamilton is moving towards psychedelic research, inspired by the great american bio chemist Alexander Shulgin. (https://melmagazine.com/en-us/story/the-magic-chemicals-of-psychedelic-wizard-sasha-shulgin) So for the future, Morris has mainly the tweaking of molecules in mind, and that in the context of a university. Hamilton and I talk about why we are developing a new idea of drugs and psychedelics as we speak, the meaning of molecules and the freedom of researching new molecules, the advantages to approach psychedelics in a completely non-judgmental and undogmatic fashion, and of course we address Hamilton's favorite topic: the Sonoran Desert toad, or Bufo alvarius and the potent psychedelic compound called 5-MeO-DMT. https://www.vicetv.com/en_us/show/hamiltons-pharmacopeia https://www.patreon.com/HamiltonMorris

The episode today will be in german, because my guest today has a good, informative way to talk about the new psychedelics, in german. Since we want to offer and communicate as much information as possible about the new psychedelics for everyone, once in a while we do a show in german. Dr. med. Andrea Jungaberle, based in Berlin, is a perfect guest for this. She is a co-founder and board member of the MIND Foundation. She also serves as OVID Health Systems’ Medical Director and MIND’s Director of Collaboration and Media. She is a clinical specialist in anaesthesia and emergency medicine and is currently training in cognitive behavioural psychotherapy. Andrea’s research interests revolve around the therapeutic application of altered states of consciousness, integration and the essential questions of death and dying. She has facilitated workshops on psychedelic integration with Dr. Henrik Jungaberle since 2015 and is a key contributor to the MIND Foundation’s BEYOND EXPERIENCE program. She is a certified Kundalini Yoga teacher, has participated in several accredited trainings in psychedelic therapy, and is part of the EPIsoDe study team, preparing to treat patients at Charité hospital in Germany’s first modern clinical trial involving psilocybin. Her interests in altered states of consciousness range from psychedelics to breathwork to yoga. In her latest audiobook “Yoga, Tee, LSD,” Andrea shines a light on the many ways humans modulate their consciousness, both intentionally and unintentionally. https://mind-foundation.org/ https://episode-study.de/hgf/

Ronan Levy, Co-Founder and Executive Chairman of Field Trip Health and I are talking about Field Trip’s mission to "bring the world to life through psychedelics and psychedelic-enhanced psychotherapy". Especially the opening of Ketamine Clinics, in the meantime in seven locations from Toronto to Amerstedam, has made Field Trip Health last year to one the most important forces in the field and last year the company even went public. Ronan, a lawyer by training, is also a partner at Grassfed Ventures, a venture capital and advisory firm focused on the cannabis and biotech industries and is Chief Strategy Officer and Member of the Board of Directors for Trait Biosciences Inc., a leading biotech company in the hemp and cannabis industries.It was fun to have Ronan on the show again and catch up, also because the world of psychedelics is changing every day. This time, next to Ketamine, we talk about if Ketamine Clinic should look like Soho House, if there is something like an agnostic molecule, we talk Demi Levato's video “Dancing with the devil'', where she shows herself overdosing and addressing her addiction. We talk about the exact meaning of “California Sober”, an approach to recovery that includes drinking alcohol and smoking cannabis in moderation and we discuss if biotech or the recreational side of psychedelics will win the race. So enjoy the show with Ronan and the birds singing in the background, while we are talking. https://www.fieldtriphealth.com/

What if some people undergoing psychedelic assisted therapy rather have a picture of Manchester United or Britney Spears on the wall, instead of a buddha and yoga poses? Is this a question of class, just a different idea of spirituality and power objects? This is my favourite topic in the episode with Ben Sessa today. Dr. Ben Sessa is consultant psychiatrist, psychedelic therapist and chief medical officer at Awakn Life Sciences , UK’s first on-the-high-street provider of psychedelic-assisted psychotherapy. Awakn is researching, developing and delivering evidence-based psychedelic medicine to treat addiction and other mental health conditions, and is aiming to open 15 to 20 clinics across the UK and EU in the next 24 months. Patients will be able to self-refer or be referred by their GP (including NHS). Ben focuses on MDMA-assisted therapies, since the substance is further along in the research and legal processes then psilocybin.Though in the meantime, Ben and his team work also with Ketamine as a therapy tool. The need for psychedelic assisted therapy seems higher then ever. Ben tells me, 30 to 40 % of the British population is drinking in a harmful bracket now in the last 12 month of the pandemic. We talk about rather different ways of using psychedelics like ketamine for addiction, MDMA for obesity or psilocybin for anorexia, something Ben, as a fan of creative psychopharmacology, is interested in. We also address what happens, if depression and anti-depressants can become part your identity and how you might be able to get rid of your own old stories about yourself with the support of psychedelic assisted therapy. http://www.drsessa.com/ https://awaknlifesciences.com/

My guest today is Zac Kamenetz. Zac is a rabbi, community leader, and aspiring psychedelic chaplain based in Berkeley, CA. He holds an MA in Biblical literature and languages from UC Berkeley and the Graduate Theological Union and received rabbinic ordination in 2012. He is also the founder of the Shefa Foundation, for Psychedelic therapy grounded in Jewish spirituality. He was part of a psilocybin study that dosed clergy of various traditions with psilocybin, the psychoactive compound found in psilocybin mushrooms. This conversation is not only exploring new territory like judaism and psychedelics. Zac and I talk the future of psychedelic therapy, in Zac case that could be jewish psychedelic teraphy, with a “jewish set and setting” as Zac describes it. We talk epigenetic trauma and experinces, the new openeness towards religions and psychedelics and why there might be the new health clubs shuls one day. Zac and I talk about how non-jewish people, like me, should start talking to other non- jewish people about the Holocaust, and how psychedelic insight can contribute to this: the recognition and the embracing of pain, guilt and responsibility. I did not expect the conversation and the podcast with Zac would turn into a psychedelic integration session. For me. But the german and jewish history is something that has been on my mind since forever. And now it is time to bring it back as a result of a psychedelic experiences. https://www.shefaflow.org/ https://2021.jewishpsychedelicsummit.org/

Today, my guest is Lars Christian Wilde, the President, Chief Business Officer and Co‑founder of Compass Pathways. Compass is a “mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.” as they describe themselves. Compass was one of the first companies engaging in a bigger vision of the substance psilocybin. But back to Lars. He is a special guest to me, since I like his open mind. I remember talking to Lars in one of our first podcasts about vaccine against depression in the future. I also remember how openly Lars talked about his treatment-resistant depression and anxiety disorder and the effects it had on him and the people in his life. He told me about his treatment with psilocybin, that helped him tremendously to begin a new life with a different mental health set. I am always a fan of people, especially entrepreneurs in the psychedelic field, that share their psychedelic experiences and are personally affected by the power of psychedelic substances. In 2020 lot of things have happened at Compass Pathways. In September 2020 the company became a public company, listing their stock on Nasdaq and raising $146.6 million. Compass became one of the most exciting company in the field. Lars and I catch up, what is happening in the Compass World right now. How does a psychedelic public company feels and works different? How does the Compass and Sheppard Pratt collaboration look like, since Compass is opening a Centre of Excellence in collaboration with The Sheppard Pratt Institute for Advanced Diagnostics and Therapeutics in Baltimore, Maryland, to do more research. Their psychiatry department exists since the 1800s. We talk about how Compass works with the Charité hospital in Berlin and how to do conduct a study in times of Covid at all, we discuss COMP360, a psilocybin therapy trial for treatment-resistant depression designed by Compass for future treatments of depression (https://compasspathways.com/)

I am happy to have Jeremy Weate, board member of Universal Ibogaine, as my guest on the show. He spent 15 years working as a consultant on natural resource governance, providing advice to governments, companies and civil society organisations in over 20 countries. Jeremy also has a decade-long interest in the medicalization of ibogaine in a holistic treatment setting. He visited Gabon in 2016 and was initiated into Bwiti. In 2018, Jeremy helped set up Tabula Rasa Retreat in Portugal, now one of the leading ibogaine treatment facilities in the world. He has organized ibogaine conferences in Vienna, Porto and London. He has a PhD in European philosophy from the University of Warwick, UK. Jeremy and I talk about the face and rules of modern addiction, the coming importance of Ibogaine and why you can’t keep a good molecule down, which is a british, understated way to say: Ibogaine will become a mayor player in the new word of psychedelics treatments. He is now a board member of "Universal Ibogaine" (https://www.ibogaineinc.com/) a Vancouver based company which aims to build a global network of holistic ibogaine-assisted addiction treatment clinics, operating under the brand Clear Sky Recovery, utilizing a proprietary Ibogaine assisted psychotherapy treatment protocol. The treatment protocol has successfully disrupted opioid addiction for over 3,500 people and delivers up to 95% successful detox.

I talk to, Charley Wininger. Great guy, experienced psychedelic pro. He is a licensed Psychoanalyst and Mental Health Counselor for individuals and couples. Charley is an author and an expert on Psychedelic Drugs, the 71-year-old is a also a relationship counsellor who calls MDMA the “relationship super glue” and just published the book called. “Listening to ecstasy” When reading about Charleys book, I was wondering: is our connection on a neural level the most important one? Charley must know. In is book he talks about his “MDMA” journey with his wife Shelley, since the two of them, you could say, became relationship scientist with the support of ecstasy. Since the ideas of marriage and relationships have changed big time and we seem to need new tools to understand each others minds and hearts. Charley and I talk about the rediscovery of MDMA in the context of the psychedelic renaissance. And how MDMA could supports couples therapy in the future and what that would mean for love. Enjoy Charley explaining a new possible “relationship glue” called MDMA. https://www.charleywininger.com/

Today’s show is all about meeting a legend called Stanislav Grof. Why “legend”? Simply, Stan was around when the first wave of psychedelic research started, but more than that, he was a thriving force in bringing psychedelics into psychiatry and helping to create a scientific base to explore psychedelics as a tool. Today, Stanislav is one of the most important sources for the new mental health industry and new psychedelic therapies. I talked to both Stan and his wife Brigitte, collaborators and partners of several years, and also because Stan had a stroke a few years ago, he feels more comfortable with Brigitte by his side. Honestly, I could not believe that this conversation was happening, the possibility to talk to someone from the first wave of psychedelics. Stan is a psychiatrist with over sixty years of experience in research of non-ordinary states of consciousness and one of the founders and chief theoreticians of transpersonal psychology. He was born in Prague in 1931 where he also received his scientific training: an MD degree from the Charles University School of Medicine and a PhD from the Czechoslovakian Academy of Sciences. He was also granted honorary PhD degrees from the University of Vermont in Burlington and the Institute of Transpersonal Psychology in Palo Alto, CA, and the World Buddhist University in Bangkok, Thailand.

 Dr Grof’s early research in the clinical uses of psychedelic substances was conducted at the Psychiatric Research Institute in Prague, where he was principal investigator of a program that systematically explored the heuristic and therapeutic potential of LSD and other psychedelic substances. Essentially, Grof was one of the first doctors using LSD in psychiatry! In 1969, Dr. Grof became Assistant Professor of Psychiatry at Johns Hopkins University, one of the most important universities now researching psychedelics now. In 1973, he was invited as Scholar-in-Residence to the Esalen Institute in Big Sur, California, where he developed, with his late wife Christina Grof, Holotropic Breathwork, an innovative form of experiential psychotherapy that is now being used worldwide. Esalen is the famous institute in California, where all the great masters of consciousness were teaching (Alan Watts was one of them). Dr. Grof is the founder of the International Transpersonal Association (ITA) and for several decades served as its president. Currently, Dr. Grof is Professor of Psychology at the California Institute of Integral Studies (CIIS) in the Department of Philosophy, Cosmology, and Consciousness in San Francisco, CA. In May 2020 Stan and Brigitte Grof launched their new training in working with holotropic states of consciousness, the Grof® Legacy Training. More Stanislav and Brigitte Grof resources: Stan Grof’s website: http://www.stangrof.com/ Brigitte Grof’s website: https://brigittegrof.com/ The Way Of The Psychonaut (film): https://www.thewayofthepsychonaut.com/ The Way Of The Psychonaut (book): https://www.amazon.com/Way-Psychonaut-One-Encyclopedia-Journeys/dp/0998276596

Today my guest is Brian Muraresku and his book has a similar game changing effect as Michael Pollan’s “How to change your mind”.… except that Brian makes us rethink psychedelics and religion. So just what will the pope have to say? Brian Muraresku graduated from Brown University with a degree in Latin, Greek and Sanskrit and he has been practicing law internationally for fifteen years. In 2016, Muraresku became the founding executive director of Doctors for Cannabis Regulation. In arbitration with the NFL in 2018, Muraresku represented the first professional athlete in the United States to seek a therapeutic use exemption for cannabis. So, what brings the man on a podcast about psychedelics? Brian and I met in an unusual place—yet a very one common for our times—in a Zoom Meeting.This is where I learned about Brian's recently released amazing book, “The Immortality Key: The Secret History of the Religion with No Name”. The Immortality Key is incredible, a journey into the psychedelic origins of the world's great spiritual practices and what those might mean for how we view ourselves and the world around us. Brian researched for 12 years, was able to get in the archives of the Vatican and check if there are any psychedelic hints (pssst …there are!). He travelled Europe to find out how ancient rituals were supported by psychedelic experiences. So did the Ancient Greeks use psychedelics to find God? And did the first Christians inherit the same, secret tradition? Brian's book and theories changed my whole idea coming from a Catholic culture, and growing up as a Catholic girl. So what if our cultures and religions were always based on psychedelic rituals? Just imagine…(https://www.brianmuraresku.com/)

Today we are checking in with a scientist again, and a really important one for our German-speaking audience. Meet Prof. Dr. Gerhard Gründer, a Professor of Psychiatry and head of the Molecular Neuroimaging Department at the Central Institute of Mental Health, Mannheim. He is the Principal Investigator of the German Psilocybin Depression Trial conducted by ZI Mannheim and Charité Berlin. He is also the Principal Investigator at the aforementioned Psilocybin Depression Study in cooperation with the MIND European Foundation for Psychedelic Research. Just a little note: this episode today will be in German, and we will talk about the first major psilocybin study, which is supported by the German government. There is tons of information about psychedelics already out there in English, but not so much in German. German-speakers, please enjoy our interview! Professor Gründer and I discuss the lack of innovation in psychiatry when it comes to medication, the old school and new schools of depression research, ketamine therapy as a temporary solution, and why depression and mental health will soon be looked at and researched in a new way.

Meet Paul Stamets, my new favourite Mr. Mushroom. Paul is an American mycologist and entrepreneur. He is an author and advocate of the “medicinal” fungi. Stamets runs “Fungi Perfecti” a family-owned, environmentally friendly company specializing in using mushrooms to improve the health of the planet and its people. Fungi perfecti has become synonymous with cutting-edge mycological research and innovative mycological solutions. Stamets has been talking about these “Mycologiclal solutions” for years and since the movie “Fantatsic Funghi” that everyone should watch, one could call Stamets the most passionate advocate of mushrooms. And yes, also Magic Mushrooms, the ones that changed Pauls life long time ago.He often talk about his experience with Magic Mushrooms and he is pretty well known for his mushrooms micro dosing protocoll. But Paul is not a big fan of using magic mushrooms in any other way then thoughtful and purposeful. And FYI,he loathes the word “shrooms”! Paul is an incredible mind, a perfect guest with millions of stories and one of them is, that Stamets once was the german name Steinmetz from Bavaria and we ended our conversation with me promising Paul to look for his ancestors in Bavaria. So, hey, let’s hear the mushrooms theories it from Paul!

David Bronner is an incredible American corporate executive and activist. As the top executive at Dr. Bronner's Magic Soaps, David has positioned himself as the “Cosmic Engagement Officer” and is known for his activism around a range of issues, especially fair trade, sustainable agriculture, animal rights, and importantly to us, drug policy reform.Full disclosure: David's company Dr. Bronner’s have a special personal meaning to me and to The New Health Club, since the company generously sponsored the podcast for most of 2020 and will continue to do so in the new year. I met David in February this year for the first time in Germany for our first podcast together and none of us knew at that time that we would experience such an exciting year in psychedelics as the one that we’ve had. Dr. Bronner’s as a company has supported the most important decriminalization movements in the US this year such as DC Measure 81–Decriminalize Nature DC, which passed with 76% of the vote and supports the enforcement of laws against natural plant medicines. You might also remember that the chairwoman of Decrim DC Melissa Lavasani was on our show before the US election! Dr. Bronner’s also supported the Oregon Model, Measure 109 which passed with 56% of the vote and legalises regulated access to psilocybin therapy administered by trained state-licensed facilitators in a therapeutic setting. The model already made a big impact on the worth of stocks from both new psychedelic companies and startups.Dr. Bronner’s also supported Decrim Chicago and the spokesperson Daniel Carcillo, an incredible ex-NHL player, who treated his depression with psilocybin. Of course, we also had Daniel on our show too, a very emotional episode indeed and please check it out if you have not done so already.I am thrilled to have David on the show as our last guest for 2020. We talk the exciting year in psychedelics, why the US (and Europe) are so ready for new mental health drugs, we discuss David's German heritage (the Bronner family is originally from Heilbronn), the next level in the upcoming psychedelic world and we are even joined by David’s dog during our talk.

I talked to Rachel Yehuda, a professor of psychiatry and neuroscience, the Vice Chair for Veterans Affairs in the Psychiatry Department, and the Director of the Traumatic Stress Studies Division at the Mount Sinai School of Medicine. She also leads the PTSD clinical research program at the James J. Peters VA Medical Center. In 2020 she became director of the Center for Psychedelic Psychotherapy and Trauma Research at Mount Sinai.Rachel is an important woman, and will be even more important in the years to come. She is researching the generational effect of the holocaust trauma. The neuroscientist and I discuss how the Holocaust, famine, and other catastrophic experiences can affect our DNA. And how MDMA therapy might be able to change that.I could not wait to talk to Rachel! She is a specialist in researching epigenetic trauma in the context of Holocaust survivors and she is a pioneer in understanding how the effects of stress and trauma can transmit biologically to the next generation. She has studied the children of Holocaust survivors and of pregnant women who survived the 9/11 attacks. How is it possible that children or grandchildren of traumatised parents struggle with anxiety and depression but not the parents themselves? And where do psychedelics fit into this picture? Rachel will also start a research program to treat these trauma-related depression with MDMA, all in collaboration with MAPS. What happens if one undertakes a psychedelic journey, and experiences their traumatic past during their trip? What does that mean for our future ability to look at the world in general? How can we do the work on post-traumatic growth? What new stories can come from exploring this psychodynamic narrative? And what tools do we need to re-story our past? Using psychedelics and MDMA can be really powerful tools in understanding conflict, shame and guilt on a deeper personal level.

My guest today is Finn Age Hänsel, Co -Founder of the Sanity Group, (https://sanitygroup.com/) which also owns the CDB Brand VAAY. (https://vaay.com/) I am big fan of their night CBD Spray called “Mind, Cosy, Back,Doze” It’s my ritual before I go to bed. But back to Finn’s tech career, so far already very impressive. He founded 5 companies. He is an Entrepreneur and CEO for 7 years with a strong passion and and knowledge for product, brand, technology and consumer goods. And he started to speak out for a cannabis decriminalisation at the age of 17, in the conservative party CDU- even more impressive. But now Finn is fully engaging in the idea of Cannabis as a tool, to make life better and healthier, his company Sanity Group is developing innovative cannabinoid-based pharmaceuticals and wellbeing products, which should be widely accessible. I talk to Finn, why and how Cannabis can be a mental health support system, why the winner of this US election are new mental heath drugs. We talk about his early days as a cannabis supporter in a political system and why life as an entrepreneur is so much better and more fun, if you have real mission. Like Finn.

Today I have Elias Dakwar MD on the New Health Club podcast. He is an associate professor of clinical psychiatry at Columbia University Vagelos College of Physicians and Surgeons. He has conducted laboratory and clinical investigations of the use of Ketamine infusions and mindfulness training to treat addictions. Ketamine is a medication mainly used for starting and maintaining anesthesia where it induces a trance-like state while providing pain relief, sedation, and memory loss. As we speak, Ketamine is being researched and used as an antidepressant and as a tool to support the outcome of psychotherapy. Scientists from Yale call it a “game changer” for psychiatry and mental health, the company Field Trip from Canada has successfully opened legal Ketamine clinics. I talk to Elias how Ketamine works, why it triggers reactions in your cortex that enable brain connections to regrow. We also talk about the possibility of a chemical mindfulness and how Ketamine can be a future tool for mental health treatments.

The world is suffering from a big metal health crisis and new mental health drugs can be the answer to this crisis. My guest on the show is working on these new drugs: JR Rahn. He is the founder & Co-CEO of Mind Med, a global company that discovers, develops and deploys psychedelic inspired medicines and experiential therapies through FDA clinical trials. JR and I talk about the current status of mental health in the US, and the world, which seems to have never been near as bad as now. “Eleven per cent of Americans seriously considered suicide in June,” Rahn observed—a doubling since last year. “We’re not O.K.” says JR and this has been the case for a while, which turned JR into a passionate founder to help research LSD and MDMA in a new way and turn them into modern mind medicine. We also address JRs personal history with trauma, we discuss the Ritalin and the Xanax generation and why they are often the ones ending up taking anti depressants later in life. I always enjoy talking to JR, I love how passionate he is in bringing the psychedelic industry and renaissance forward, an I love how thinks I sound like a german spy from homeland. https://www.mindmed.co/

My guest on the show today is Dr. Monnica T. Williams, certified licensed clinical psychologist and Associate Professor at the School of Psychology at the University of Ottawa. She received her undergraduate degree from M.I.T. in 1992 and she holds a Doctoral Degree in Clinical Psychology from the University of Virginia. Monnica is researching how PTSD symptoms can result from racism and what racial trauma and race-based trauma look like. Monnica also researches, partly in the context of MAPS, how to treat racial trauma with psychedelic-assisted therapy, such as with MDMA or Ketamine.I also talk to Monnica about diversity in the psychedelic science field, about the effects MDMA-assisted therapy can have on racial trauma, and what happens if your therapist might not be aware of their own racism. I think the questions we need to ask if it comes to the topic of race and mental health are quite endless. And we are only just starting.

We have a patient story on our hands today. And an athlete story. It is the story of Daniel Carcillo, who still goes under the Twitter -Name “CarBombBoom13” Daniel was known as “Car Bomb” during his NHL (National Hockey League) career because he played — and lived — with reckless abandon. According to his doctor, he also had seven diagnosed concussions. They contended that the NHL knowingly withheld information about the dangers of hockey-related brain injuries, actively promoted fighting and failed to assist players in the transition from the ice to everyday living.” writes the NYT. After suffering from depression, concussion and traumatic brain injury, Daniel tried everything, but nothing helped, his state of mind and body got worse. How does it feel, when your tried everything “under the sun”, as Daniel says. Finally, Daniel found someone, who gave him access to a so called hero dose, a very high dose, of psilocybin, which helped Daniel to come back to a life, his life. Now, Daniel wants to support the “traumatised community” he once came from, he is a plant medicine and fungi advocate. He is a farmer and entrepreneur with a fully integrated cannabis and medicinal mushroom business. Now, Daniel is the face of the decriminalise Chicago movement, talking about his journey with psychedelics, using them as a tool to heal.

Melissa Lavasani’s story in a nutshell: After suffering from a depression that nothing seemed to help, she finally learned about the potential of plant medicine (via a Podcast!) - but what would the other Moms at her children’s school say? Would she have to break the law to save herself? Well she made the choice to prioritise her mental health, and eventually started to thrive, which inspired her to become the force behind Decriminalise Washington - a political initiative helping decriminalise magic mushrooms and plant medicine so they can be used to treat depression.In the podcast, we talk about the so-called Baby Blues, which is the nice and easy word for postpartum depression and we talk about why becoming a mother is a full on identity crisis and can trigger things one never thought about. We talk about how a normal mum can be the best spokesperson for psychedelics and why it's good to convince as many republicans as possible, especially in the upcoming election, that psilocybin will help to save lives.

Brazil alert! My guest today is Dr. Bia Labate, a queer Brazilian anthropologist, ayahuasca expert, sociologist, author and cofounder of the Chacruna Institute. Bia Labate is one of the real experts in the field of plant medicine. And there is a lot to talk about, much more than just vomiting in a bucket, after drinking the psychedelic tea.When it comes to plant medicines, drug policy, shamanism, ritual, and religion, Bia is a pro and her Chacruna Institute is an organization that provides public education about psychedelic plant medicines and promotes a bridge between the ceremonial use of sacred plants and psychedelic science. Bia and I discuss Ayahuasca as a spiritual mentor, a teacher, a friend, as something that gives you homework to do with yourself and as something that is deeply rooted in South American culture. Bia has 23 years experience with Ayahuasca, a plant that gave her the feeling of “being at home for the first time”. We also talk about cultural appropriation and mindfulness towards the indigenous people, who are the ones providing the knowledge and the substances, diversity. https://chacruna.net/ https://www.bialabate.net/

Graham Boyd is the co-founder and Executive Director of The Psychedelic Science Funders Collaborative (PSFC) and the Political Director at Dr. Bronners. And a huge driving force behind the MDMA-as-medicine movement. We are proud of Graham, since he helped complete the MAPS Capstone challenge, a Psychedelic Research Fundraising Campaign that just has attracted $30 Million in donations in just 6 months which will prepare MDMA-Assisted Psychotherapy for FDA Approval. If successful, this would be the first-ever psychedelic-assisted psychotherapy to earn approval from the FDA. Graham has spent his career fighting on behalf of social justice causes. Through his work advocating for those who have been marginalized, Graham was introduced to psychedelic science. Recognizing that those who will benefit from physician-prescribed MDMA and psilocybin are often suffering in silence, he brings his expertise from past efforts to help raise funds and resources to further the FDA process and bring much-needed relief to veterans, abuse survivors and others who are struggling with PTSD, depression and anxiety.

My guest Deborah Mash is one cool research lady from Miami. She’s tough, educated, and all-too familiar with the drug wars in Miami, a series of conflicts that took place between government and cartels during the ‘70s and ‘80s. She knew a Miami that was flooded with cocaine and champagne, resulting in mass addiction problems across society, and who are looking for new tools to beat addiction to this day. Mash is an American professor of neurology and pharmacology at the Leonard M. Miller School of Medicine, director of the Brain Endowment Bank at the University of Miami, and is the CEO of her company DemeRx. In the ‘90s, Mash and her team found a third substance that addicts produce if they use alcohol and cocaine at the same time, a molecule that makes addiction impossible to beat. Deborah called it the “Miami Vice Metabolite” and spent a lot of time researching how both the molecule and the resulting addiction could be handled.From very early on, Mash was an expert on heavy substance abuse, addiction that was destroying the many people’s lives. Now she’s researching Ibogaine, a natural indole alkaloid derived from the West African iboga plant. In African traditional medicine and rituals, chewing the yellow-coloured root or bark is used to produce hallucinations. Now, Mash and ATAI Life Sciences explore the ibogaine substance as a new mental health drug to beat alcohol, heroin and other opioid addiction.

I talk to Amanda Feilding, the “Countess of Psychedelics Science”, who you could say was somewhat of a psychedelic and scientific socialite in the sixties, and who has been a strong advocate behind the resurgence of psychedelic science and reform. Also known as Lady Neidpath and the Countess of Wemyss and March, she lives in Beckley Park, an estate just outside Oxford. Amanda’s contribution to global drug policy reform and early psychedelic research has been pivotal and widely acknowledged. She was first introduced to LSD in the mid-sixties, at the height of the first wave of scientific research into psychedelics. Impressed by its capacity to initiate mystical states of consciousness and heighten creativity, she quickly recognised its transformative and therapeutic powers. Today she is the owner of the Beckley Foundation, a UK-based think-tank and UN-accredited NGO, dedicated to activating global drug policy reform and initiating scientific research into psychoactive substances.

My guest on the show today is Amanda Eilian. Amanda is an investor, the co-founder of __able partners, together with Lisa Blau in New York City. Able Partners is an investment fund focused on supporting visionary, early stage brands in the positive living space. And yes, Amanda has invested in Gwyneth Paltrow’s GOOP empire. Listening to Amanda feels like you hear a flawless lecture on the current state of investment in psychedelics. But also on the reasons, why psychedelics are on the rise. One of them: our increased (and commercialised) search for wellness, is a sign of a heavily inadequate social system and so, at one point the wellness “classics” like yoga, mindfulness, talk therapy, extremely healthy eating and mediation apps seem not enough any more to help us through life: the effect certain societies and surroundings have on us, can’t be resolved with simple “wellness” and “mindfulness” bumper stickers any more. Amanda plays an important part in introducing psychedelics to the lifestyle and the new wellness world. The “New York Times” recently featured able partners in the article “The Capital That Ate Wellness Is Going to Eat Your Mushrooms . Venture capital arrives for psychedelics” Able partners are also focused on areas that have historical stigma often resulting in underserved markets, meaning that Amanda is investing in companies dealing with mental health or sexual wellness. In this episode, Amanda and I talk Covid19 times, the new era of mental health, and why there is a problem with our old idea of wellness.

German-born Gisela is also a photographer, film director, and author. She was part of the sixties and seventies bohemian milieu, mixing with the likes of Dennis Hopper, Hunter S. Thompson, Jack Nicholson, Leonard Cohen, and of course Timothy Leary, the controversial psychologist who researched LSD. But beyond all these job descriptions, Gisela is also a “lifelong seeker”. Gisela and her twin sister Jutta Winkelmann were highly involved in Germany’s “68 Movement”, but they always sought more, more than just belonging to a political movement. They wanted a meaningful life, rich with experience and trying everything that was available. Gisela then married John Paul Getty, they lived in California and they surrounded themselves with likeminded people who were also into new ideas and thinking about the world and humankind, which of course at that time, was heavily influenced by psychedelics. This meant that Gisela was around, when psychedelics became popularized in Western culture for the very first time, and also when the use of psychedelics was very much aligned with changing a whole society and the world.

Christian Angermayer is an entrepreneur, investor and a thriving force in the current psychedelic field. He is the founder of Apeiron Investment Group and the biotech company ATAI Life Sciences. ATAI’s focus is developing solutions to help the more than 300 million people globally who suffer from depression. Their research explores the use of psychedelic compounds to heal a broad range of mental health disorders alongside depression. This is Christian’s second appearance on the show. In this episode we really dive into his personal journey towards psychedelics and how he became a driving force in this exciting new industry. And we also talk about racial trauma, and the new ways we’re beginning to understand it and redefine our notions of mental health on a broader scale.

On today's podcast, I talk with JR Rahn, the CEO and Founder of MindMed. Their work involves creating transformative medicines to address big problems in society like anxiety, ADHD and addiction. They are achieving this through the use of psychedelic inspired medicines. Right now, MindMed is collaborating with the psychedelic research lab at the University of Basel and the University of Maastricht. JR and I discuss his journey from working at Uber to founding a leading psychedelic company which aims to create the “antibiotic for addiction”, as he says. We talk about JR’s investor Kevin O’Leary (Mr. Wonderful) from the TV Show Sharktank, and we discuss why prominent public figures like him could have a powerful impact on the de-stigmatisation of mental health and psychedelics.

Today, I talk to Rick Doblin, the Founder and Executive Director of MAPS (Multidisciplinary Association for Psychedelic Studies) A “non-profit research and educational organisation that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.” Some people say Rick is a “Mensch” and that’s yiddish for a a person of integrity and honour, which I would like to confirm 100% regarding Now, after decades of focused, strategic effort, MAPS has achieved securing FDA approval to conduct a Phase III study of a psychedelic drug – in this case MDMA – for treatment-resistant PTSD.

This week, my guest is coach Dr. Michael Franz. And he could be one of the coaches helping to create a new kind of company: the one for our future, Michael supports CEOs, Principals & Entrepreneurs and their teams creating “agreeable” futures as he says. What makes him a unique guest for the show? Well he is an executive coach, who is guiding business-oriented medical plant journeys for CEOs & Entrepreneurs - actually very established ones. Michael is interested in how psychedelics enable leaders and himself to be much more present, empathetic, courageous, innovative and impactful.

I talk to Robin Carhart Harris about an important tool of the future: psychedelics. Robin has the aura of your typical “cool scientist” and heads the Psychedelic Research Group within the Centre for Psychiatry at Imperial College London. He has designed a number of functional brain imaging studies with psilocybin, LSD, MDMA and DMT, plus a clinical trial of psilocybin for treatment resistant depression. Carhart-Harris is the first person in the UK to have legally administered doses of LSD to human volunteers since the Misuse of Drugs Act of 1971. He is passionate about finding proof, that we need new mental health drugs.

For the premier episode of the “Heal Soul!” series in colaboration with Dr. Bronner’s I speak with Michael Pollan, an American journalist who has written several articles and a book about the new psychedelic science in connection with addiction and depression, including “How to Change Your Mind”. During the interview, Pollan emphasizes that in his opinion psychedelics are wasted on the young and can be more useful later in life. He believes that psychedelic therapy will be available in Britain and the US within the next few years. For him it is greatly fascinating to have access to such a powerful tool to treat depression and post-traumatic stress disorder (PTSD).

Dr. Rosalind Watts is the clinical lead at “Imperial Centre for Psychedelic Research”, which is connected to the Imperial College in London. One of the most important psychedelic research centers right now. Rosalind’s Ted Talk “Can Magic Mushrooms unlock depression” was one of the first talks I have ever seen on the topic of psychedelics. I loved Rosalinds very human, very patient support driven approach to the topic of psychedelic therapy and treatment resistant depression. I also love that we had great laugh about, how she and her university friends lived above a magic mushrooms shop in Birmingham back then. But our talk is about the future of psychedelic therapy, about micro dosing and how it can make you cry, instead of being super focused on “work stuff” and if it is a good thing, that our "business as usual" is interrupted now. “Hunger for nature, spending time together and new experiences is what we are seeing right now. And psychedelic therapy can play a huge role in this.” says Watts.

We are going full entertainment and Netflix here! I talk to Donick Cary, the director of the Netflix movie called “Have a good trip”. Cary interviewed Sting, Deepak Chopra, Rosie Perez, Ben Stiller, Anthony Bourdain, Cary Fisher and Sarah Silverman about their psychedelic trips and how their lives and minds changed after their psychedelic experience. For good. Donick Cary gets the movie right, since he is a big shot Hollywood writer: he worked as the head writer at Late Night with David Letterman, he wrote for The Simpsons, Parks and Recreation, HBO’s Silicon Valley. Carys uses a specific kind of humour, since he is trained in his writing for the Simpsons and Letterman. So how do you talk psychedelics with celebrities and make it entertaining and not an ego driven trip bragging? And will celebrities talking about this change the public opinion about these new tools? Well, if humour is part of the equation, “people will listen” says Cary. Or, as Deepak Chopra says “Life a trip,” and psychedelics might help to improve your ride.

I talk to Zack Haigney the founder of the Trip Report, a cool, new newsletter on the Business, Policy and Impact of Psychedelics The Trip Report monitors the Business, Policy, Regulation, Science and Cultural Impact of Psychedelics and aims to be the go-to media outlet. Zach, not unlike myself, started to be involved in the psychedelic industry not that long ago and I like the way he is reporting and reflecting in his newsletter on all that is happening now so fast in the current psychedelic ecosystem. We talk how do to a good newsletter and if and why psychedelic can be political. One day. that’s what Zach and I agreed on, we will run a mantel wellness morning show.

I am talking to Ronan Levy from "Field Trip Health" based in Canada. The company is providing clinics for evidence based legal psychedelic therapies to treat depression. But what I like about "Field Trip Health" is their attitude towards a really dated idea to call some people “sick” or “crazy”. Field Trip Health says, we treat people, not patients. “We are all sick and healthy at the same time. It’s just that some people need more support.” says Ronan.We discuss the design places for a psychedelic treatment should have. Should they look more like a spa? Or a clinic? Or do we need new designs? And do the “ well" need psychedelics to get “better"? Or should we only focus on clinically depressed people? But then again, these concepts and terms don’t work any more. Join me and Ronan talking new psychedelic solutions and why mindfullness is not enough anymore.

A mental wellness philosopher, that is what I call Elise Loehnen. She is now the “chief content officer” at goop.com, the health company founded by Gwyneth Paltrow. She is in charge of the language that is used at Goop, especially if it comes to mental wellness and mental health. I think that Elise created a whole new language around mental wellness, especially in her Goop Podcast she cohosts with Gwyneth Paltrow: because we need a completely new language to address mental health. “Crazy” or “depressed” doesn’t do the job any more. Listen to Elise and me, exchanging Psilocybin-Experiences and trying to make sense of the current cultural PTSD during and after Covid19.

Up for a little biotech and psychedelics? I talked to Florian Brand, Co-Founder and CEO of the ATAI Lifescience. ATAI is “committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in the mental health space.” So ATAI as a company is on the forefront to heal mental health disorders, the are one of the first “superstar” companies, to speak in a Hollywood language, in the new psychedelic field. Also, like in so many other cases of founders in this field, Florian has experienced a psychedelic treatment and healing, that made him a believer in the new compounds.

Have your heard of PRE-TSD? The fear of things to come ? Most Health Workers are suffering from this, plus a proper PTSD after their time at the “frontline” as we call it now. I talk to Karen Dougherty from Ontario in Canada, the founder of the Ontario Covid Mental Health Network. She is a psychotherapist and psychoanalyst. She came up with a briliant idea. She created a network of therapists, that help to support nurses, doctors, erveryone working on the frontline. At this point, for them this can feel like going into a war zone. Which means they might have to deal with PTSD later, but often with a PRE-TSD: the plain fear of what can happen to them if they go to work in the morning. Karen has developed a great model therapists can copy & paste.

This time I talk to Ayelet Waldman who talks refreshingly open about her microdosing experience with LSD and becoming a modern empath through the experience: she just founded FeedER to support health workers with food during the Covid19-Crisis. Ayelet is a very successful Israeli-American novelist and essayist, has written many novels, TV Shows like “Unbelievable” on Netflix. Her book “A Really Good Day: How Microdosing Made a Mega Difference in My Mood, My Marriage, and My Life” is a fascinating diary about that little blue bottle in Ayelets fridge: LSD in a microdose.

Welcome to the new world we are operating in now aka the world of ZOOM and Yoga pants all day. In the upcoming podcast our guest is Lars Christian Wilde, President and Co-founder of COMPASS Pathways. COMPASS is a mental health care company “dedicated to accelerating patient access to evidence-based innovation in mental health”. COMPASS is currently looking into the beneficial effects of psilocybin-assisted psychotherapy for treatment-resistant depression. There are so many questions right now. Will large portions of our society suffer from at least a mild form of PTSD after this current crisis? Will there be a whole new world of psychedelic investors, since we need new tools now more than ever? I loved how Lars explained why psilocybin gummi bears won’t be the future of the psychedelic movement. Also, the Covid-19 crisis might mean: psychedelic-assisted treatment could become more important than ever.Lars also discussed a possible vaccine for mental health disorders that we might have access to in a few years which would be useful in situations such as our current crisis.

This time I talk to the british fun- gentleman Dr Ben Sessa. He is an approved MDMA and psilocybin psychotherapist. currently a senior research fellow at Bristol and Imperial College London Universities. He is a co-founder and director of the UK's Breaking Convention conference. Dr Sessa is becoming well known for his MDMA trials and did a TED Talk about treating child hood trauma with MDMA in 2016. Sessa thinks MDMA could be psychiatry’s antibiotic. I talk to Ben about trauma and a possible cure with MDMA. So what if after the crisis we are experiencing now in times of Covid-19 will leave a lot of people with traits of PTSD aka post traumatic stress disorder?

Our guest on the podcast today, Brian D. Earp. He’s the Associate Director of the Yale-Hastings Program in Ethics & Health Policy at Yale University and The Hastings Center, and a Research Fellow in the Uehiro Center for Practical Ethics at the University of Oxford. He’s the co-author of Love Drugs along with Julian Savulescu. We talk about ‘love drugs’: Could psychedelics serve as a catalyst for falling in and out of love? Sounds like a futuristic invention or a movie premise, but it’s the topic of Brian D. Earp’s new book: Love Drugs: The Chemical Future of Relationships. Brian talks science, no science fiction. So what about an ‘anti-love drug’? Maybe to help us get over an ex-partner? As much as some psychedelic-assisted experiences may help couples strengthen their emotional ties, others might help individuals let go of their emotional connections during a difficult break-up. These substances, like MDMA (the active ingredient in ecstasy), already exist, and they can have profoundly transformative effects on our feelings of love. Enjoy!

In this episode I am having a conversation with David Bronner, the CEO or Chief Cosmic Engagement Officer of Dr. Bronner’s. Dr. Bronner's is the top-selling soap in the U.S. natural marketplace. They only use the purest organic & Fair Trade ingredients, and they are a third-generation Jewish soap maker from Heilbronn, Germany. We talked psychedelics and how a company works, if it is run by a Cosmic Engagement Officer, a CEO with a psychedelic experience and lifestyle. Dr. Bronner’s is involved in the new psychedelic world, supporting MAPS (https://maps.org/), where David sits on the board. Plus: the company supports several decriminalise nature campaigns. David’s jewish ancestors were killed in Theresienstadt and Auschwitz. So we talked how inherited holocaust trauma could be cured with the help of psychedelics and how this might become a serious treatment.

In this episode I am having a conversation with Martijn Schirp, Co-Founder of Synthesis, a legal, modern, guided psilocybin retreat in Amsterdam. I went there last weekend, drank magic truffle tea and the insights were incredible. Martijn and his team manage to create an extraordinary atmosphere to dive in a psychedelics mushroom aka truffle experience. Over a weekend. Today, we talk answering big life questions with the help of psychedelics, finding your real purpose with the help of a truffle, just in case you lost it. We explain what to do against pre-trip nervousness, why Gwyneth Paltrow show is here now and why magic mushrooms can be a tool for our challenging times, if taken in the right set and setting. Enjoy the ride!

In this episode I am talking psychedelics & mental health. My guest is one of the thriving forces in the new psychedelic world: Christian Angermayer, the founder of Apeiron Investment Group and ATAI Life Science. Angermayer is not your typical VC. He knows the spiritual background of psychedelics, the latest studies, the secrets of greek philosophers, if it comes to doing psychedelics. If you need a little bit of an obsessed counter part to talk psychedelics, he is your man! Enjoy!

Hi everyone! just a quick announcement from our side. You used to find the “Surviving Tech” podcast here. But from now this is the place to find “The New Health Club” podcast. Now, why this new podcast? I got very interested in the new psychedelics, since they are experiencing a renaissance, developing into a tool to help us go through life. But what are LSD, magic mushrooms, psilocybin and MDMA or Ketamine are exactly doing for our mental health, personal progress and optimisation? Will they change our lifestyles and lives forever? I am sure, they will. On the “New Health Club Podcast” I talk to real innovators, thought leaders and disrupters from the emerging world of psychedelics. The New Health Club is where conversation around the new era of psychedelics begins. It’s a lifestyle. With no judgements. It’s all about an emerging neural awareness. Join us in becoming your own neural expert. We are happy to have you as our guest! And just a few things are changing. From now on, all podcast are going to be in english, we are starting on a monthly basis. Our first topic on january 16th will be psychedelics and mental health. So tune in, we are happy to see you! Instagram: https://www.instagram.com/the.newhealthclub/ Website: https://www.thenewhealthclub.de/